Read More Pharma Industry News Pasithea Therapeutics raises $60m in discounted public offering as biotech funding momentum returns Find out how Pasithea Therapeutics’ $60 million stock offering reshapes its clinical runway, dilution outlook, and investor sentiment. bySoujanya RaviNovember 28, 2025